CausalSentinel

Protein Dossier — LDLR (Low-density lipoprotein receptor)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Non-cancer illness code self-reported: high cholesterol -0.174 0.0363 1.57e-06 Wald ratio 1 trans NA
Forced expiratory volume in 1-second (FEV1) 0.0378 0.00974 1.04e-04 Wald ratio 1 trans NA
Forced vital capacity (FVC) 0.033 0.00923 3.57e-04 Wald ratio 1 trans NA
Systolic blood pressure automated reading -0.0378 0.0115 0.00102 Wald ratio 1 trans NA
Body mass index (BMI) -0.0332 0.0113 0.00313 Wald ratio 1 trans NA
Diagnoses - main ICD10: R10 Abdominal and pelvic pain -0.161 0.0642 0.0122 Wald ratio 1 trans NA
Non-cancer illness code self-reported: hypertension -0.0506 0.0202 0.0122 Wald ratio 1 trans NA
Diagnoses - main ICD10: I48 Atrial fibrillation and flutter 0.212 0.087 0.0151 Wald ratio 1 trans NA
Bulimia nervosa -0.0787 0.0324 0.0152 Wald ratio 1 trans NA
Endometrioid ovarian cancer -0.336 0.139 0.0158 Wald ratio 1 trans NA
Non-cancer illness code self-reported: emphysema or chronic bronchitis -0.311 0.136 0.0222 Wald ratio 1 trans NA
Diagnoses - main ICD10: C50 Malignant neoplasm of breast -0.258 0.116 0.0258 Wald ratio 1 trans NA
…and 65 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

1403 association rows across 670 traits (1363 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Low density lipoprotein cholesterol levels 9e-2305 rs73015024 49 GCST90239655 no MR -> candidate analysis
Total cholesterol levels 2e-1793 rs73015024 61 GCST90239673 no MR -> candidate analysis
Non-HDL cholesterol levels 8e-1498 rs73015024 7 GCST90239667 no MR -> candidate analysis
Apolipoprotein B levels 9e-830 rs6511720 25 GCST90019496 no MR -> candidate analysis
LDL cholesterol 2e-522 rs147985405 13 GCST90018961 no MR -> candidate analysis
Low-density lipoprotein levels 5e-380 rs17242381 2 GCST90662892 no MR -> candidate analysis
Cholesteryl Esters in Medium VLDL 3e-340 rs12151108 3 GCST90501208 no MR -> candidate analysis
Phospholipids in IDL 2e-327 rs12151108 4 GCST90501129 no MR -> candidate analysis
Free cholesterol in IDL 6e-321 rs12151108 3 GCST90501125 no MR -> candidate analysis
High cholesterol 1e-320 rs12151108 6 GCST90475205 MR: beta=-0.174, p=1.57e-06 (trans)
Concentration of IDL particles 5e-319 rs12151108 8 GCST90501128 no MR -> candidate analysis
Free cholesterol in small LDL 7e-311 rs73015024 4 GCST90501250 no MR -> candidate analysis
…and 658 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1670 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
hypercholesterolemia, familial, 1 0.991 established (curated) no MR -> candidate analysis
Hypercholesterolemia 0.974 0.987 established (curated) MR: beta=-0.174, p=1.57e-06 (trans)
familial hypercholesterolemia 0.941 0.953 established (curated) no MR -> candidate analysis
homozygous familial hypercholesterolemia 0.868 established (curated) no MR -> candidate analysis
coronary artery disorder 0.973 0.978 multi-layer: burden+GWAS (allelic-series candidate) no MR -> candidate analysis
metabolic disease 0.977 0.983 multi-layer: burden+GWAS (allelic-series candidate) no MR -> candidate analysis
heart disorder 0.936 0.951 multi-layer: burden+GWAS (allelic-series candidate) no MR -> candidate analysis
hyperlipidemia 0.853 0.615 established (curated) no MR -> candidate analysis
angina pectoris 0.907 0.842 multi-layer: burden+GWAS (allelic-series candidate) no MR -> candidate analysis
Disorder of lipid metabolism 0.905 0.936 multi-layer: burden+GWAS (allelic-series candidate) no MR -> candidate analysis
metabolic syndrome 0.89 established (curated) no MR -> candidate analysis
myocardial infarction 0.9 0.731 multi-layer: burden+GWAS (allelic-series candidate) MR: beta=-0.04, p=0.41 (trans)
cardiovascular disorder 0.796 0.257 multi-layer: burden+GWAS (allelic-series candidate) no MR -> candidate analysis
coronary atherosclerosis 0.921 common-variant locus no MR -> candidate analysis
Other metabolic disease 0.93 0.93 exploratory rare-variant signal no MR -> candidate analysis

Of the 15 rows above, 13 have no MR estimate in this resource. Across all retrieved diseases for this gene: 4 exploratory rare-variant signal(s), 8 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Low-density lipoprotein receptor)
gnomAD constraint pLI=1.3e-32, LOEUF=1.12 — LoF-tolerant
GWAS Catalog 203 unique SNPs / 528 rows
ClinVar 4921 records; 15 pathogenic in sample of 30
PharmGKB/ClinPGx 6 clinical annotations across 6 drugs

Caveats declared by the tools

Sources

Provenance